Hecla Mining well-positioned for growth after 2024 results, says H.C. Wainwright
H.C. Wainwright analyst Heiko Ihle reiterates a Buy rating on Hecla Mining (HL) shares after the company reported 2024 financial results. The ...
H.C. Wainwright Sticks to Their Buy Rating for Viking Therapeutics (VKTX)
H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Viking Therapeutics (VKTX – Research Report) today and set a price target ...
HC Wainwright Has Lowered Expectations for Largo (NYSE:LGO) Stock Price
Largo (NYSE:LGO – Get Free Report) had its target price cut by investment analysts at HC Wainwright from $4.20 to $3.70 in a report released on Wednesday,Benzinga reports. The firm currently has a ...
What is HC Wainwright’s Forecast for CRBP FY2029 Earnings?
Analysts at HC Wainwright issued their FY2029 earnings estimates for shares of Corbus Pharmaceuticals in a note issued to investors on Monday, February 10th. HC Wainwright analyst A. Maldonado expects ...
Why Ocugen (OCGN) Is Advancing Today
Ocugen (OCGN) is climbing 5% after investment bank H.C. Wainwright raised its price target on the shares to $8 from $7.
H.C. Wainwright cuts Compass Pathways stock target to $45
H.C. Wainwright analyst Patrick Trucchio revised the price target on Compass Pathways (NASDAQ:CMPS) stock, reducing it to $45 ...
Hosted on MSN4d
HC Wainwright & Co. Downgrades Pliant Therapeutics (PLRX)
Fintel reports that on February 10, 2025, HC Wainwright & Co. downgraded their outlook for Pliant Therapeutics (NasdaqGS:PLRX ...